RICHARD W KRAMP
CIK 936971 · President and CEO · last filed 2023-08-07
RICHARD W KRAMP is a President and CEO who has filed 26 SEC Form 4 insider transactions across 4 companies since 2008. The most recent filing, for NVEC, was dated Aug 7, 2023. Across all open-market trades the lifetime net is −$551.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $24.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$24.7K
4
26
-$551.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NVEC | Director | 225 | $109.84 | $24.7K | $0 | 10 | 2023-08-07 |
| VASCULAR SOLUTIONS INC (VASC) Delisted | Director | 9,910 | — | — | $34.9K | 5 | 2017-02-09 |
| ROCHESTER MEDICAL CORPORATION (ROCM) Delisted | Director | 12,281 | — | — | $0 | 1 | 2013-02-04 |
| SYNOVIS LIFE TECHNOLOGIES INC (SYNO) Delisted | President and CEO | 66,698 | — | — | -$586.7K | 8 | 2011-05-27 |
Recent Filings
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-08-07 | NVEC | Grant (A) | — | $0 | EDGAR |
| 2023-05-10 | NVEC | Exer (M) | +575 | $50.2K | EDGAR |
| 2022-08-05 | NVEC | Grant (A) | — | $0 | EDGAR |
| 2021-08-31 | NVEC | Grant (A) | — | $0 | EDGAR |
| 2020-08-10 | NVEC | Grant (A) | — | $0 | EDGAR |
| 2019-08-02 | NVEC | Grant (A) | — | $0 | EDGAR |
| 2018-08-03 | NVEC | Grant (A) | — | $0 | EDGAR |
| 2017-08-04 | NVEC | Grant (A) | — | $0 | EDGAR |
| 2017-02-22 | — | Disp (D) | −9,160 | $0 | |
| 2017-02-09 | VASCULAR SOLUTIONS INC (VASC) Delisted | Gift (G) | −750 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.